410 related articles for article (PubMed ID: 9477617)
21. Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
Tsui KH; Chang PL; Wang TM; Hsieh ML
Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):23-8. PubMed ID: 9178589
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
Smart R
N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
[TBL] [Abstract][Full Text] [Related]
24. [The value of PSA density for the diagnosis of prostatic cancer and for the indication of radical prostatectomy].
Doublet JD; Ciofu C; Fouret P; Gattegno B; Thibault P
Prog Urol; 1995 Apr; 5(2):211-9, 220; discussion 219-20. PubMed ID: 7536529
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen.
Lodding P; Aus G; Bergdahl S; Frösing R; Lilja H; Pihl CG; Hugosson J
J Urol; 1998 Mar; 159(3):899-903. PubMed ID: 9474178
[TBL] [Abstract][Full Text] [Related]
26. Detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/mL.
Kim HS; Jeon SS; Choi JD; Kim W; Han DH; Jeong BC; Seo SI; Lee KS; Lee SW; Lee HM; Choi HY
Urology; 2010 Oct; 76(4):919-22. PubMed ID: 20303152
[TBL] [Abstract][Full Text] [Related]
27. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
28. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
[TBL] [Abstract][Full Text] [Related]
29. [Systematic ultrasound guided transrectal core prostate biopsy based on serum level of prostate-specific antigen].
Yamaguchi S; Baba Y; Naito K
Hinyokika Kiyo; 1997 Sep; 43(9):641-5. PubMed ID: 9365843
[TBL] [Abstract][Full Text] [Related]
30. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
Akduman B; Alkibay T; Tuncel A; Bozkirli I
Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
[TBL] [Abstract][Full Text] [Related]
31. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
32. [Detection of prostatic cancer in symptomatic patients with serum levels of prostate-specific antigen between 4 and 10 ng/ml].
Ravery V; Schmid HP; Billebaud T; Toublanc M; Boccon-Gibod L; Hermieu JF; Delmas V; Boccon-Gibod L
Presse Med; 1996 Feb; 25(7):272-6. PubMed ID: 8685164
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
Ellis WJ; Chetner MP; Preston SD; Brawer MK
J Urol; 1994 Nov; 152(5 Pt 1):1520-5. PubMed ID: 7523710
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of the anatomical location of ultrasound-guided systematic sextant prostate biopsies for the nodal status of patients with localized prostate cancer.
Dunzinger M; Sega W; Madersbacher S; Schorn A
Eur Urol; 1997; 31(3):317-22. PubMed ID: 9129923
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
Stewart CS; Leibovich BC; Weaver AL; Lieber MM
J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
[TBL] [Abstract][Full Text] [Related]
36. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
Rahardjo D; Kamil ST; Pakasi LS
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
[TBL] [Abstract][Full Text] [Related]
37. Indications for extended 14-core transrectal ultrasound-guided prostate biopsy.
Uno H; Nakano M; Ehara H; Deguchi T
Urology; 2008 Jan; 71(1):23-7. PubMed ID: 18242358
[TBL] [Abstract][Full Text] [Related]
38. [Relation of age and prostatic volume to cancer detection in prostatic biopsies from patients with non-suspect rectal palpation].
Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Subira Ríos D; Castaño González I; Moralejo Gárate M; Martínez Salamanca JI; Cabello Benavente R
Arch Esp Urol; 2003 May; 56(4):359-66. PubMed ID: 12830608
[TBL] [Abstract][Full Text] [Related]
39. Incidental carcinoma of the prostate.
van Andel G; Vleeming R; Kurth K; de Reijke TM
Semin Surg Oncol; 1995; 11(1):36-45. PubMed ID: 7538693
[TBL] [Abstract][Full Text] [Related]
40. [Puncture biopsy of the prostate].
Lechevallier E
Prog Urol; 1996; 6(4):507-18. PubMed ID: 8924925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
